Impact of COX2 on Sera Biomarkers From Obese Subjects

Completed · Early Phase 1

Conditions studied: Breast Cancer Survivors

In brief

Obesity promotes worse outcome for post-menopausal breast cancer patients.

Key facts

Study ID

NCT02062255

Run by

The University of Texas Health Science Center at San Antonio

People needed

126

Starts

2013-10-01

Expected to finish

2016-04-01

Last updated by the study team

2016-10-26

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• At least 18 years of age
• Post-menopausal as confirmed by medical history
• Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator's IRB/Ethics Committee

You may not qualify if…

• Evidence of active cancer (patients with a prior history of malignancy are encouraged to participate, but due to cytokine levels associated with malignancy there must be no evidence of disease)
• Cachexia
• Active systemic illness (infection including viral illnesses such as Hepatitis and HIV)
• Chronic use of aspirin of omega-3 free fatty acid supplementation within the last 60 days (defined as greater than or equal to 7 consecutive days)
• Known hypersensitivity to aspirin and/or omega-3 fatty acids
• Actively receiving a physician-directed regimen of aspirin and/or receiving herapeutic/prophylactic anticoagulation
• Any aspirin or omega-3 free fatty acid supplementation within the last 14 days
• Subjects who are pregnant
• History of medical noncompliance

Where it is running

• Cancer Therapy and Research Center at UTHSCSA — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.